
Ember Therapeutics, Inc.
Ember Therapeutics, Inc. (EMBT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EMBT · as of Jun 15, 2026
Key Statistics
Explore Ember Therapeutics, Inc. Data
embt stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
embt competitorsStock Performance
Full HistoryAbout Ember Therapeutics, Inc.
Ember Therapeutics, Inc. operates as a biopharmaceutical company currently in its clinical development phase. Its core mission involves exploring the therapeutic applications of bone morphogenetic pro…
what is ember therapeutics, inc. · embt stock overview · ember therapeutics, inc. company profile · who is ember therapeutics, inc. ceo · embt OTC · ember therapeutics, inc. headquarters · ember therapeutics, inc. business segments
About Stock Overview & Key Data
Ember Therapeutics, Inc. (EMBT) is a Healthcare company in the Biotechnology industry, listed on OTC since Oct 21, 2015. As of the latest trading session, EMBT stock price is $0.00, with a market capitalization of $398. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2014, Ember Therapeutics, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ember Therapeutics, Inc. (EMBT) stock price is $0.00. The stock is traded on OTC under the ticker symbol EMBT. The 52-week range is $0.00 – $0.00.